Wound closure and wound care devices are the medical apparatus used for the closure of the wound by pulling the cut edges of the tissues together or by directly acting on the wounds for better healing. Devices such as sutures, strips, sealants and adhesives, clips, staples, energy based devices, haemostats and skin grafts are used to minimize the trauma and infection leading to a better and a scar-free healing. The wound closure and advanced wound care global market is segmented based on the products, applications, end-users and geography. Products are divided into primary and secondary wound closure products. Primary wound closure devices include surgical sutures, wound closure strips, staples, ligating clips, haemostat, adhesives and sealants. Surgical suture market is segmented into suture and automated suturing device. Suture market is further divided based on types, filaments, and material type. Sealants are divided into natural and synthetic sealant. Natural sealants are collagen, fibrin and albumin. Synthetic sealants are divided into cyanoacrylate, polymer and others. Haemostats are divided into flowable haemostats, fibrin sealants, mechanical haemostats and active haemostats.
Secondary wound closure devices include energy based devices, therapy based devices, moist wound therapy and biologics. Energy based devices are divided into laser devices, electrical stimulations, electromagnetic stimulations, ultra sound therapy, radio frequency therapy and ultra violet therapy. Therapy based devices are further segmented into hyperbaric oxygen therapy, negative pressure wound therapy and pressure relief devices. Biologics are divided into skin grafts and growth factor. Moist wound therapy is segmented into film, foam, hydrocolloids, hydrogels, alginate and collagen dressings.
By application, the wound closure and advanced wound care markets are divided into burns, ulcers, surgical wounds, trauma and laceration and radionecrosis. Ulcers are further divided into pressure ulcers, arterial ulcers, venous leg ulcers and diabetic foot ulcers. Surgical wound are divided into general surgery, cardio vascular surgery, neuro and spine surgery, ENT surgery, orthopaedic surgery, urology surgery, oncology surgery, obstetrics and gynaecology surgery and plastics, cosmetics and reconstruction surgery. Based on the end- users they are segmented into hospitals, community healthcare services and home healthcare.
Among the wound closure and advanced wound care products, the primary wound closure market dominated the products market by occupying a largest share. At the same time, secondary wound closure market is the fastest growing segment from 2014 to 2021. In applications, the surgical wounds are the largest segment with XX% share and ulcers are the fastest growing segment with single high digit CAGR from 2014 to 2021. By end- users, hospitals is the largest segment with a share of XX% and also, the fastest segment with a CAGR of 7.4% from 2014 to 2021.Geographical wise, North America is the largest market, followed by Europe and Asia. The APAC region is the fastest growing region with single high digit CAGR from 2014 to 2021 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the wound closure and advanced wound care market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The wound closure and advanced wound care market is expected to grow steadily CAGR during 2014 to 2021. The factors driving the growth of this market are rising prevalence of lifestyle diseases such as diabetes and cardiovascular and related surgeries drive the demand for sophisticated tissue sealing alternatives, new technology products boosting wound closure and advanced wound care products market growth, increase in aging population, increase in volume of surgeries, government initiatives and wide range of available products likely to propel the wound care market. In addition to this, increasing prevalence of chronic wounds, optimised therapy based devices, healthy growth in the biological products and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market. However, lack of trained physicians restraining market growth of advanced wound closure and care products, high cost of sealants and glues impeding effective penetration in low- and middle-income countries, unfavourable reimbursement policies and reluctance in adoption of new technologies are hampering the growth of the market. The threats for the wound closure and advanced wound care market include survival of small players & new entrants and decreasing R&D funding will impact on innovation.
The wound closure and advanced wound care global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.
Some of the key players of the wound closure and advanced wound care market are Smith & Nephew (U.K.), Johnson and Johnson (U.S), Medtronic (Ireland), 3M healthcare (U.S), Kinetic Concepts (U.S.), Coloplast (Denmark), Abbott laboratories (U.S.), C.R.Bard (U.S.), Baxter International (U.S.),Cardinal Health (U.S.), Integra life science (U.S.) and B. Braun Melsungen AG (Germany).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Rest of the World (RoW)
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)